mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
0.62 |
0.02 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.02 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
BRD-K51490254 |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.02 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.02 |
mRNA |
BRD-K35604418 |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.02 |
mRNA |
A-804598 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.02 |
mRNA |
PDMP |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.03 |
mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.03 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.03 |